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Available online 12 May 2016Background: Plain radiography is the ﬁrst choice for diagnosis and monitoring of knee-osteoarthritis (OA) while,
Kellgren–Lawrence score (KL) is most widely used to grade OA severity. However, incompetency for
reproducibility of joint space measurement in longitudinal assessment and non-linearity of KL-score system,
limits radiography-based early diagnosis of the disease. Glycosaminoglycan (GAG) is direct cartilage-degradation
product, which can be measured biochemically. We strived to correlate KL-score and GAG from OA patients to
compliment KL-system.
Methods:We obtained 34 synovial-ﬂuid (SF) samples from 28 OA patients (few bilateral) with different disease
severity using arthrocetesis. All patients were categorised using radiographic KL-score-system. SFs were further
analysed for GAG estimation using 1,2-dimethylmethylene blue (DMMB) assay.
Results: A substantial increase in GAG was noted in KL-grade-II and III, comparing grade-I patients, indicating
ampliﬁed cartilage-degradation. KL-grade-IV patients revealed further rise in GAG reﬂecting more
cartilage-loss. Another category of grade-IV patients with lower GAG were also detected, indicating close
to total cartilage-loss.
Conclusions: Accurate diagnosis of cartilage-loss remains a challenge with OA due to limitations of
KL-system; thus no target intervention is available to arrest active cartilage-loss. We propose,
GAG-estimation in OA patients, characterizes accurate biochemical depiction of cartilage degeneration.
General Signiﬁcance: Radiology often fails to reveal an accurate cartilage loss, associated with OA. GAG
levels from the SFs of OA patients' serve as a useful marker, which parallels cartilage degeneration and
strengthen radiographic grading system, ultimately
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Cartilage is considered as an engineering marvel that handles
remarkable pressure on weight bearing joints. Extracellular matrix
and aggrecan, a water-laden proteoglycan, provide cartilage with a
great tensile strength, stiffness and resistance for deformation.
Progressive degeneration of articular cartilage is a hallmark of
osteoarthritis (OA), which results in pain and loss of function. OA is
expected to get worsen as we experience a global rise in obesity
and associated knee injuries. Cartilage degradation is a combined. Kulkarni),
r@gmail.com (S. Koppikar),
gmail.com (D. Ingale),
. This is an open access article underoutcome of ineffective physical force management and molecular
damage. Disrupted cartilage metabolism involves depolymerizing
enzymes like metalloproteinase, which releases glycosaminoglycan
(GAG) [1,2].
At present, plain radiography remains a priority of orthopaedic
clinicians to monitor and assess OA progression [3] whereas Kellgren–
Lawrence Score (KL) is the most widely used radiographic metric. This
system is based upon radiographic features like Joint Space Narrowing
(JSN) and osteophytes formation. Easy access, cheap cost, short imaging
time and less discomfort to patients are common advantages associated
with radiography. However, scope of plain radiography is limited due to
conﬁnes such as, lack of reproducibility of joint space measurement in
longitudinal assessment, joint positioning, non-linearity in KL grades
and little information about the rate of cartilage degeneration [4].
It is well understood that a variety of matrix molecules and their
degradation products are released by degrading cartilage, which canthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Estimated GAG values and KL-scores of studied patients.
Sr. no Patient no. KL score GAG
1 P1 I 0.8
2 P2 I 39.2
3 P3 I 3.8
4 P4 I 9.2
5 P5 I 20.9
6 P6 I 48.9
7 P7 II 142.0
8 P8R II 119.5
9 P8L II 138.1
10 P9 II 145.6
11 P10 II 180.0
12 P11 II 113.8
13 P12 II 167.2
14 P13 III 113.8
15 P14 III 186.6
16 P15 III 112.9
17 P16 III 141.9
18 P17 III 125.8
19 P18R IV 394.2
20 P18L IV 448.3
21 P19 IV 392.5
22 P20 IV 437.5
23 P21R IV 342.9
24 P21L IV 356.7
25 P22 IV 66.5
26 P23 IV 76.4
27 P24R IV 177.6
28 P24L IV 156.2
29 P25R IV 149.2
30 P25L IV 159.6
31 P26 IV 49.7
32 P27R IV 79.5
33 P27L IV 101.4
34 P28 IV 81.1
Fig. 1. A graphical presentation of GAG estimation in enrolled OA patients.
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aggrecan, serve a vital function of providing tensile strength to collagen
ﬁbrillar network. GAG levels in synovial ﬂuid (SF) would therefore
reﬂect cartilage degenerative changes associated with OA [2].
In the present communication, we attempted to correlate GAG
and KL grades of OA patients with an objective to complement the
limitations of KL-score system. To evaluate this hypothesis, we enrolled
28 OA patients with different disease severity and obtained 34 SF
samples, including a few bilateral samples. These SFs underwent GAG
analysis and obtained GAG valueswere further comparedwith patient's
KL score to establish a correlation between clinical parameter and
cartilage degeneration.
2. Materials and methods
2.1. Patient and KL-score assessment
For the present study, we recruited 28 patients with varied OA
severity. The disease diagnosis was performed by clinical assessment
(knee pain for at least six months and on the majority of days during
the preceding month) and radiology. Typical anterio-posterior (AP) or
lateral view X-ray of affected knee joint (standing) was obtained and
graded for KL-score. The radiographic features like JSN, presence of
osteophytes and sub-chondral sclerosis were considered while grading.
The characteristics for each KL-grade can be summarized as, grade I —
doubtful OA with presence of minor osteophytes of doubtful impor-
tance, grade II—minimal OA, with deﬁnite osteophytes but unimpaired
joint space, grade III — moderate OA, with osteophytes and moderate
diminution of joint space whereas grade IV — severe OA, with greatly
impaired joint space and sclerosis of subchondral bone [6].
2.2. Collection of SFs
SFs aspiration of the enrolled OA patients, who had a knee effusion,
was performed under strict aseptic precautions. The affected knee was
cleaned; draped and arthrocentesis was carried out using 18 gauge
needle and 10-cc sterile syringe. Single needle prick method was
adopted to avoid contamination; in the ﬁrst step skin was punctured
which was followed by the puncture of synovial capsule. Enrolled
patients were briefed about the aim and objectives of this study and
voluntary consent was obtained for the participation.
2.3. Evaluation of GAG
The collected SFs were further analysed for their GAG estimation.
GAG levels were measured by a spectrophotometric dye binding
assay, using 1,2-dimethylmethylene blue (DMMB) with chondroitin
sulphate as standard [7]. The levels were expressed as microgram
equivalents of chondroitin sulphate per ml SF.
All the protocols were approved by the Institutional Ethical
Committee, constituted for this purpose (BVDU/MC/56).
3. Statistical analysis
The collected data was statistically analysed using two independent
samples t-test. The severity of cartilage degradation, in terms of GAG
value, was compared among radiographic KL grades.
Inter-grade comparison (grade I to IV) of KL-score was performed
with their respective GAG values using SASUniversity software (Edition
1.0). Aftermany experiments, a p value less than 0.05was considered as
an indicator of signiﬁcant difference.
4. Results
KL grade I (N= 6) showed high statistically signiﬁcant difference in
GAG valueswhen compared to KL grade II (N=7), grade III (N=5) andgrade IV patients (Table 1). However, difference in GAG remained non-
signiﬁcant in between KL grade II and grade III (p= 0.6395). Both the
categories represent moderate to severe JSN, indicating noteworthy
cartilage degradation.GAG estimation from KL grade IV also remained
remarkably higher when compared to grade II and grade III (p = 0.
0001, p= 0. 0001 respectively). A graphical presentation of GAG esti-
mation from all the studied patients is shown in Fig. 1.The statistical data analysis of obtained samples is summarized
in Table 2.
5. Discussion
Knee pain is shown to have a poor correlation with cartilage degen-
eration [4,8]. Thus, the active cartilage degeneration phase (CDP) is
Table 2
P values after the application of pooled ‘t’ test comparing
KL-score and GAG estimation in studied patients.***
KL grades ‘p’ value
I and II 0.0001***
I and III 0.0001***
I and IV 0.0001***
II and III 0.6395
II and IV 0. 0001***
III and IV 0.0001***
⁎⁎⁎ Statistical signiﬁcance at 1%.
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asymptomatic for quite a long time; but it is also difﬁcult to predict
the stage at which cartilage degradation begins and reaches the peak.
The present data revealed high GAG estimation in all SFs than its
documented normal value [9], whichwere reﬂective of loss in aggrecan
and thus the damaged cartilage [10]. GAG values of KL grade I patients,
however found the lowest among all KL-grades, as an indicator of early
OA. On the other hand, high GAG in all grade II patients was
complementing the KL-score by radiographically detectable OA. The
same trend continued with all KL-grade III patients and remained
comparable with grade II.
Based on the GAG estimation, grade IV patients, however, were
divisible into two categories. First category (patient P18 to P21)
revealed a very high GAG, suggesting a peak of active cartilage degener-
ation process. It explained a transition from grade III to grade IV i.e. to-
wards terminal stage of the disease. On the other hand, patients from
second category (P22 to P28) were found with signiﬁcantly low GAG
levels. Cartilage in these patients was completely worn-out extending
a profound loss of joint space, as observed from the radiographs.
Interestingly, we found the similar research observations reported by
Waluka et al, where a possibility of ‘ﬂoor effect’ was predicted in end-
stage OA patients (KL grade IV) because of a very little leftover cartilage
or its absolute loss [11]. We strongly believe, the category II with lower
GAG, represented the same ‘ﬂoor effect’ as mentioned above.
Cartilage remodelling is a continuous event pivoted by a delicate
balance between anabolic and catabolic process. A marginal shift
towards catabolism gradually leads to cartilage loss and further the
disease development, which remains asymptomatic for quite a long
time. It is suggested that cartilage degeneration process in OA is
not linear and rate of OA progression calculated by joint space
width (JSW) widely varies from 0.06 mm/year to 0.6 mm/year.
Based upon MRI imaging of 123 OA subjects, Waluka et al had
estimated tibial cartilage volume loss at the rate of 5% per year
[11]. Thus, it takes 1–2 years or even longer to detect the progression
of damage being visible on radiographs because of its insensitive
reﬂection of disease process [5]. By the time clinical characteristics
features like joint pain, stiffness and dysfunction are diagnosed
(evaluated by the clinical assessment in the form of limited range
of motion and instability) a signiﬁcant cartilage loss has already
resulted. Since cartilage loss cannot be detected earlier, it has not
been a therapeutic target so far.
Williams et al. 2004 has emphasised a need for further research to
unravel biochemical changes during OA progression, this is to comple-
ment delayed-gadolinium-enhanced MRI of cartilage (dGEMERIC), an
emerging non-invasive technique for GAG estimation [12]. The present
study was completely attributed to scrutinize GAG values ranging from
early OA to the terminal stage of the disease; thus, could be beneﬁcial
to reveal an insight of biochemical picture of cartilage degeneration in
OA [12].
Although, conventionally OA is considered as awear and tear disease
and one may believe that exercise will not be helpful for its manage-
ment or even worsen the situation. On the contrary, physical exercise
has been shown to have protective effect against cartilage-loss inOA-animal model [13]. Further, Williams et al. 2004 has found higher
GAG contents in knee-cartilage of professional dancers and those who
exercise regularly. Moreover, moderate physical activity (like running)
plays a beneﬁcial role along with nutritional supplements in the OA
patients with initial low GAG estimation [12]. This study is an excellent
example for underscoring the importance of GAGmonitoring in OA and
its utility in effective disease management.
We are aware that limited number of SFs in each KL grade is a con-
straint of the present study due to invasivemethod of sample collection.
However, based on the current data, GAG level proved to be a useful
marker, being a true indicator of cartilage loss within the knee joint.
GAG estimation from SF of OA patient strengthens KL grading system,
which will ultimately help clinicians to prescribe an effective therapy.
To conclude, KL-score system often fails to reveal a transition from
one grade to next, unless there is a substantial cartilage loss, which is
an irreversible process; thus, revealing a dichotomy between the active
CDP and KL score. As this crucial gap remains un-attempted in the
present scenario, arresting progressive cartilage loss is not yet a
therapeutic target. Here, we attempted to evaluate a correlation
between KL-score system and GAG. Although, the invasive nature may
limit its disease prognostic value, being a direct degenerative product
of cartilage, GAG represents a true biochemical picture of cartilage
degeneration.
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